To assess clinical relevance, we analyzed mRNA profiles from The Cancer Genome Atlas (TCGA) BC cohort and found that TACC3 mRNA levels positively correlated with E2F3 copy number status (Fig. S1E). This evidence concerns the gene E2F3 and breast cancer.